Injection

An outbreak study based in West Virginia showed that people who inject drugs and have had hepatitis C are at risk for additional complications of injection drug use, including HIV hepatitis A and hepatitis B infection.

Rafa Laboratories announced the FDA has granted approval for its 10 mg midazolam autoinjector to treat status epilepticus in adults.

DORC International has received FDA 510(k) clearance for Eva Nexus, the first surgical system cleared for subretinal injection, according to a press release.

Vupanorsen (Ionis) for reduction of non-HDL in patients with hyperlipidemia already on statin therapy.

Revance Therapeutics announced the FDA has accepted its Biologics License Application resubmission for daxibotulinumtoxinA for injection for the treatment of moderate to severe glabellar lines, according to a company press release.

Cara Therapeutics Inc. announced that Korsuva injection received CMS transitional drug add-on payment adjustment in the anti-pruritic functional category.

Imaging should be the preferred choice over palpation in guiding targeted procedures and injections at peripheral and sacroiliac joints, and at structures encompassing peripheral nerves, according to new EULAR “points to consider.”

LAS VEGAS — Among patients with gastroparesis, pyloric botulinum toxin may be effective among those with lesser pyloric impairments. However, those with worse pyloric dysfunction may not benefit, according to a presentation.

Amzell BV, a specialty pharmaceutical development company, announced it has a special protocol assessment agreement with the FDA for a phase 3 trial of its injectable infantile epileptic disease therapy.

Treatment with biologic injections may lead to serious complications, such as infections requiring multiple surgical procedures and inflammatory reactions, according to published results.